Castuner

VerifiedRx

Vizient Center for Pharmacy Practice Excellence

Delivering short doses of insight for hospitals’ frontline pharmacists, Vizient pharmacy leader Gretchen Brummel brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.

Podcastaren webgunea

Entzun zure aplikazioan

Atalak

136 atal

  1. Clinically Integrated Supply Chain: Pharmacy’s Role Across the Enterprise 19:38
  2. Advancing access to cell and gene therapies through the Advanced Therapeutics Alliance 18:05
  3. Don't set it and forget it: Managing biosimilar formularies dynamically 14:20
  4. 2026 Joint Commission Medication Management Update 13:35
  5. Oral Arguments: Enlicitide, the first oral PCSK9 inhibitor for dyslipidemia 12:39
  6. More than a building: the business case for consolidated pharmacy services centers 20:07
  7. Insights from the Summer 2026 Spend Management Outlook 14:43
  8. More than a brand: Strategic botulinum toxin decisions 12:05
  9. From clinician to executive: Developing pharmacy’s next leaders 15:56
  10. Peeling back the layers of learning in residency programs 17:47
  11. Healthcare without walls: The growth of consumer - driven care 15:17
  12. Beyond revenue: Measuring specialty pharmacy team value 12:42
  13. Alpha-gal syndrome and impact on patient safety 13:31
  14. Efficiency to excellence: AI’s role in modern pharmacy practice 17:01
  15. Inside the Medicare Transaction Facilitator: Early wins and growing pains 10:07
  16. Checkpoint change: Rethinking how PD-1/PD-L1 inhibitors are delivered 12:28
  17. Winter 2026 Spend Management Outlook 19:32
  18. CDC childhood immunization schedule updates (January 2026) 12:01
  19. 2026 OPPS final rule: What hospitals need to know 19:44
  20. The GOAT of GPO’s 18:45
  21. Return of pipeline 2026 – cell and gene therapies 24:25
  22. Pipeline 2026: The movers, the shapers, & what matters 18:37
  23. Beyond the formulary: Evolving enterprise P&T committees 16:37
  24. Challenges with AI in pharmacy 17:02
  25. Inside the clean room – Safely handling cell & gene therapies 23:44
  26. Tapping into NTAP 18:02
  27. GLN Changes You Can’t Ignore 18:27
  28. Inside the New Joint Commission Manual 21:47
  29. Partners in Prevention: A Unified Approach to Drug Diversion 16:57
  30. Beyond Humira: What’s Driving Drug Spend Now? 15:40
  31. Let’s fix this: 2024 drug shortage survey results 16:21
  32. Built to Last: Rx for Resilience 13:20
  33. COVID Vaccine Realities for 2025–26 19:48
  34. Reverse Distribution needs your attention 21:42
  35. NaV-igating pain - channeling suzetrigine 18:04
  36. From Scale to Spend: The GLP-1 Surge 22:55
  37. Rash decisions - The current measles outbreak in the US 24:07
  38. Reversal Revisited: Agents for the Management of Factor Xa Inhibitor-Associated Bleeding 17:17
  39. Dose of data: Drug shortage KPIs 20:00
  40. What's pneu part 3: pneumococcal vaccines update 21:49
  41. No pain, much gain? 17:43
  42. Winter Spend Management Outlook 10:13
  43. The Administrations, they are a-changing! 15:58
  44. Rabies - You don't know what you know 18:49
  45. Proceed by Number – Data Approaches to Drug Shortages 16:02
  46. Cha Ching Chemotherapy - Untangling the Cost of Cancer Treatment 9:15
  47. Helene Aftermath - Baxter Production Shortage 20:20
  48. Pharmacy Vision Awards - Professional Excellence: UCSF 14:31
  49. Take a Deep Breath: RSV Vaccinations Information 21:29
  50. Pharmacy Vision Awards - Ochsner: “Gar-On-Tee” Innovations 29:20